Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders
Neuromuscular disorders (NMDs) comprise a heterogeneous group of disorders that affect about one in every thousand individuals worldwide. The vast majority of NMDs has a genetic cause, with about 600 genes already identified. Application of genetic testing in NMDs can be useful for several reasons:...
Main Authors: | Andrea Barp, Lorena Mosca, Valeria Ada Sansone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/4/701 |
Similar Items
-
Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients
by: Jihye Park, et al.
Published: (2019-10-01) -
Applicability of next generation genetic testing in epilepsy through whole exome sequencing
by: Daniela Catereniuc, et al.
Published: (2020-10-01) -
Genetic cause of epilepsy in a Greek cohort of children and young adults with heterogeneous epilepsy syndromes
by: Ioannis Zaganas, et al.
Published: (2021-01-01) -
Clinical Profiles and Genetic Spectra of 814 Chinese Children With Short Stature
by: Chang, G., et al.
Published: (2022) -
Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?Key points
by: Carmen Espinós, et al.
Published: (2020-08-01)